| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0004 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |